ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., March 25, 2025 (GLOBE NEWSWIRE) -- Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a ...

BERWYN, PA — Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) has commended Nanomerics for the successful completion of a human study utilizing its proprietary Molecular Envelope Technology (MET).

The company states: “Virpax Pharmaceutical would like to congratulate Nanomerics on completing a human study using the Molecular Envelope Technology and showing no moderate to severe adverse events.

International process systems and operation experts have launched high-tech startup Crystallization Systems Technology Inc. (CrySyst) to streamline processes used by companies in the pharmaceutical ...

Purdue University-connected startup Molecular Intelligence supports research scientists in bioengineering, medical science and pharmaceutical companies who use cryo-EM to determine 3D structures of ...